#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diabetes insipidus Acute lymphocytic leukaemia Erythema Sarcoma Oesophageal adenocarcinoma stage III Isodicentric chromosome 15 syndrome Thalassaemia alpha Pulmonary sarcoidosis Muscular dystrophy Juvenile psoriatic arthritis Solitary fibrous tumour Central nervous system lymphoma Pituitary-dependent Cushing's syndrome Pancreatic carcinoma Mantle cell lymphoma More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia Haemophagocytic lymphohistiocytosis – Life with Disease Turner’s syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome Idiopathic inflammatory myopathy – Treatment IgA nephropathy – Life with Disease Medulloblastoma – Trials in Disease Cystic fibrosis Breast angiosarcoma metastatic Hairy cell leukaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betamethasone Dipropionate Pervi-Fus Fludarabine Phosphate RIVASTIGMINE Specific Nucleic Acid Sna-Xfsb STREPTOCOCCUS VIRIDANS Hydrocortisone Crizotinib Palonosetron Hydrochloride POLYSORBATE 80 Mometasone Xtmab-16 Tedizolid Phosphate Efruxifermin Gelatin VELPATASVIR Felzartamab Fexofenadine NALOXEGOL Ranibizumab More therapies…

    Learn about Your Condition

    Lymphoma Somatic symptom disorder Renal transplant Pyrexia Clinically isolated syndrome Rheumatoid arthritis Arthroscopy Osteomyelitis acute Transplantation complication Erythema migrans Menopausal symptoms Alcohol use disorder Rheumatic disorder Neutropenia Hypoalbuminaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Spain

  • Prognostic H2[15O] PET Imaging Study in Patients with Coronary Artery Disease Using O15‑Water, Adenosine and Regadenoson

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • O15-Water
    • Adenosine
    • Regadenoson
    Sweden

  • Tranexamic Acid versus Placebo for Reducing Infection after Mid‑and Hind‑Foot Arthrodesis in Adults with Deformity or Osteoarthritis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    Finland

  • Verteporfin for Scar Prevention in Patients After Surgical Wounds

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VERTEPORFIN
    • Saline
    Denmark

  • Prevention of acute kidney injury after cardiac surgery in infants and neonates using carperitide (HANP injection 1000) – randomized controlled trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Acute kidney injury
    Sweden

  • Phase II/III trial of autologous dendritic cells loaded with allogenic mesothelioma lysate in patients with borderline resectable pancreatic cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
    The Netherlands
Previous Page
1 … 12 13 14 15 16 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!